Breast cancer treatment cost in Turkey

Breast cancer treatment cost in Turkey by stage, tumor biology, and care sequence

A useful estimate begins with confirmed pathology, stage, estrogen and progesterone receptors, HER2 status, and the reason for surgery-first or medicine-first care. It then separates breast and node surgery, reconstruction, radiotherapy planning and fractions, chemotherapy, endocrine or targeted medicines, supportive care, pathology, and surveillance rather than presenting one incomplete package.

How much does breast cancer treatment cost in Turkey?

For international patients, breast-conserving surgery or mastectomy without complex reconstruction in Turkey is commonly budgeted at TRY 329,000 to 846,000 (about USD 7,000 to 18,000). A multimodal early or locally advanced pathway involving pathology, surgery, radiotherapy, and systemic treatment may reach TRY 705,000 to 2,115,000 (about USD 15,000 to 45,000), while HER2-targeted, immunotherapy, metastatic, or complex reconstructive care can exceed that range substantially.

USD illustrations use approximately TRY 47 per USD, close to the official indicative selling rate on 17 July 2026. Drug and implant quotations may be issued in EUR or USD; confirm the controlling currency, brand or biosimilar, dose, cycle count, and quote-validity period.

Review cost scenarios Upload reports

Let Us Help You

Share the basics and the Virello team will guide you toward the next step.

Prefer email? Write to support@virellohealth.com.

Patient Name

Country

Phone Number

Describe The Current Medical Problem

Reviewed 2026-07-19

Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team

Billing context: TRY and USD

Receptors direct treatment

ER, PR, and HER2 results, plus stage and selected genomic information, can change the treatment sequence and medicine budget more than the operation itself.

Lumpectomy usually links to radiation

Breast conservation is commonly followed by radiotherapy; comparing lumpectomy price alone with mastectomy can therefore misstate complete cost and time.

Reconstruction is its own plan

Immediate or delayed implant or tissue reconstruction changes surgeon teams, implants, operating time, stay, revision risk, and the timing of radiotherapy.

Pathology must travel home

Carry the final report, slides or blocks where permitted, receptor results, node findings, margin status, stage, treatment summary, and surveillance plan.

Cost at a glance

Planning scenarios for breast cancer treatment in Turkey

The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.

Estimated breast cancer treatment cost scenarios in Turkey
Scenario	TRY	USD	Patient and treatment context	Planning scope
Localized surgery-led pathway	TRY 329,000 - 846,000	USD 7,000 - 18,000	Confirmed localized disease proceeding to lumpectomy or mastectomy with sentinel-node evaluation and no immediate complex free-flap reconstruction.	Should identify breast and axillary surgery, pathology, anesthesia, stated admission, routine medicines, margin review, drains, and early follow-up.
Multimodal early or locally advanced care	TRY 705,000 - 2,115,000	USD 15,000 - 45,000	Neoadjuvant or adjuvant chemotherapy, surgery, radiotherapy, and receptor-directed treatment sequenced over several months.	Needs a phase-by-phase budget because drug, radiation, reconstruction, and response-assessment costs occur at different times.
Advanced or high-cost biologic pathway	TRY 1,410,000 - 3,290,000+	USD 30,000 - 70,000+	HER2-positive, triple-negative, recurrent, or metastatic disease requiring prolonged targeted therapy, immunotherapy, repeated imaging, or complication care.	Estimate by named medicine and planned duration; no responsible team can guarantee a fixed total before response and toxicity are known.

Usually included

Check the clinical package scope

Breast and node operation

Named lumpectomy or mastectomy procedure, sentinel-node mapping or stated axillary work, surgeon, anesthesia, theatre, and routine consumables.

Confirm whether localization, mapping isotope or dye, frozen section, and drain supplies are included.

Standard pathology

Specimen processing, histology, margins, nodes, grade, and routine receptor reporting within the stated package.

Genomic assays, outside slide review, and advanced molecular tests may be separate.

Specified hospital stay

The room category and number of ward or recovery days described in the quotation.

Obtain daily rates after the package allowance and separate ICU rates.

Early surgical follow-up

Wound and drain review, routine dressing, pathology discussion, and a written referral to the next treatment phase.

Ask how seroma aspiration or wound complications are billed.

Confirm separately

Charges that may sit outside the range

Breast reconstruction

Plastic-surgeon fee, implant or expander, mesh, flap harvest, microsurgery, extra theatre time, and later symmetry procedures unless explicitly named.

Request a separate reconstructive scope and revision policy.

Radiotherapy course

Consultation, CT simulation, planning, physics quality assurance, breath-hold or motion management, every fraction, and treatment review.

Price the complete prescribed course, not one session.

Systemic medicines

Chemotherapy, anti-HER2 treatment, immunotherapy, endocrine therapy, growth factors, anti-nausea medicines, and port care.

Use generic name, brand or biosimilar, dose, interval, and planned number of administrations.

Unexpected treatment

Positive-margin re-excision, wider node surgery, infection admission, flap or implant problem, thrombosis, severe drug toxicity, or disease restaging.

Keep a contingency beyond the base quote.

Candidate context

Who may be considered and what else may be discussed

Treatment depends on whether the finding is in situ or invasive, tumor and node stage, metastatic status, histologic subtype and grade, ER and PR expression, HER2 status, menopausal status, genetic risk, other illnesses, pregnancy considerations, and the patient’s priorities. Multidisciplinary review should decide whether surgery comes first, whether systemic therapy should shrink or test the tumor first, and how radiation and reconstruction fit. A price table cannot choose the sequence.

Information that shapes suitability

Diagnosis and extent

Core-biopsy pathology, breast and axillary imaging, and stage assessment distinguish DCIS, localized invasive disease, inflammatory presentation, and distant spread.

Tumor biology

Hormone receptors, HER2, grade, proliferation information, and selected germline or tumor testing influence chemotherapy, endocrine, targeted, and immune treatment.

Breast and axillary options

Tumor-to-breast size, multifocality, prior radiation, genetics, response to therapy, and preference shape conservation, mastectomy, and node strategy.

Whole-person priorities

Fertility, pregnancy, menopause, cardiac function, bone health, lymphedema risk, work, caregiving, appearance, and access to long-term medicines deserve explicit planning.

Alternatives or sequencing questions

Breast-conserving therapy

Lumpectomy followed by appropriate radiation can be an option for selected patients, with margin and cosmetic considerations discussed before surgery.

Mastectomy with or without reconstruction

Removal of the breast may be recommended or preferred in particular anatomy, genetic risk, recurrence, prior-radiation, or patient-choice situations.

Systemic therapy before surgery

Chemotherapy, HER2-targeted treatment, endocrine therapy, or immunotherapy may be used first in selected subtypes or stages to guide and improve local treatment.

Systemic or symptom-directed advanced care

Metastatic treatment generally prioritizes disease control, quality of life, and symptom relief rather than a routine curative surgery package.

Procedure variations

Why the named procedure does not have one price

Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.

Lumpectomy and sentinel-node biopsy

Removes the tumor with a margin and samples the first draining nodes when indicated.

Include localization, margin management, node mapping, and the expected radiotherapy phase.

Mastectomy

May be simple, skin-sparing, nipple-sparing, unilateral, or bilateral according to anatomy, disease, risk, and reconstruction plan.

Bilateral surgery should not be assumed medically necessary.

Immediate reconstruction

Implant, expander, or autologous tissue reconstruction occurs during the cancer operation.

Potential radiation and complication effects must be discussed before committing.

Delayed reconstruction

Reconstruction occurs after cancer surgery and sometimes after radiation or systemic treatment.

This creates a later operation and separate travel and recovery budget.

City comparison

Cost and capability by city in Turkey

Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.

Estimated breast cancer treatment costs and planning context by city in Turkey
City	Local range	USD range	Capability context	Stay planning
Istanbul	TRY 376,000 - 2,350,000+	USD 8,000 - 50,000+	Broadest private and academic access to breast surgery, reconstruction, molecular pathology, radiation, and systemic therapy.	Premium hospitals, accommodation, and cross-city travel can raise the complete-course budget.
Ankara	TRY 352,500 - 2,115,000+	USD 7,500 - 45,000+	Strong public, university, and private multidisciplinary oncology and radiation programs.	Confirm how international self-pay access and medicine procurement work at the chosen institution.
Izmir	TRY 329,000 - 1,880,000+	USD 7,000 - 40,000+	Established surgical, medical, and radiation oncology services in selected tertiary centers.	Check whether reconstruction and the entire radiation course occur at the same site.
Antalya	TRY 352,500 - 1,974,000+	USD 7,500 - 42,000+	International-patient coordination is accessible, with oncology depth varying between hospitals.	Separate hospitality bundles from pathology, drugs, fractions, and complication care.
Bursa	TRY 305,500 - 1,692,000+	USD 6,500 - 36,000+	Potential value for surgery and selected multimodal treatment at qualified tertiary programs.	Verify molecular pathology, plastic surgery, and radiation scheduling before choosing by price.
Kocaeli and Gebze	TRY 329,000 - 1,880,000+	USD 7,000 - 40,000+	Marmara-region centers can provide integrated care near Istanbul transport routes.	Calculate repeated journey time if radiation or infusions require daily or frequent attendance.
Adana	TRY 305,500 - 1,692,000+	USD 6,500 - 36,000+	Selected regional academic and tertiary programs support breast oncology pathways.	Confirm receptor testing turnaround and access to the named medicine.
Konya	TRY 282,000 - 1,551,000+	USD 6,000 - 33,000+	May offer value for selected surgery and standard oncology where multidisciplinary services are documented.	Do not fragment surgery, pathology, radiation, and medical oncology without a shared plan.
Kayseri	TRY 282,000 - 1,551,000+	USD 6,000 - 33,000+	Tertiary oncology review may be available for selected patient pathways.	Assess flight connections and management of treatment delays or fever.
Gaziantep	TRY 282,000 - 1,410,000+	USD 6,000 - 30,000+	Regional availability requires hospital-level confirmation for reconstruction and advanced medicines.	Require a named team and complete sequence before committing.

Estimate variables

What can change the final hospital cost

Stage and treatment intent

DCIS, localized invasive, locally advanced, recurrent, and metastatic disease use different sequences and durations.

Ask the oncologist to name intent and each planned phase.

Receptor and genomic results

ER, PR, HER2, germline risk, and selected genomic assays can add tests and substantially alter medicines.

Do not price systemic therapy before essential pathology is complete.

Surgical extent and reconstruction

Breast conservation, mastectomy, node surgery, implant, flap, and revision needs change teams and admission.

Separate oncology surgery from reconstruction in the quote.

Drug identity and duration

Generic chemotherapy, biosimilar or originator biologic, dose, body size, interval, and months of therapy drive wide variation.

A per-cycle range is not a complete course.

Radiation technique and fractions

Whole-breast, chest-wall, nodal, boost, hypofractionated, conventional, and breath-hold plans differ.

Get one price for simulation through final fraction.

Medical cost breakdown

Before admission, in hospital, and after discharge

Diagnostics and preparation

Pathology confirmation

Slide and block review, histology, grade, ER, PR, HER2, and repeat or confirmatory testing where needed.

Discordant reports should be resolved before treatment.

Breast and axillary imaging

Diagnostic mammography, ultrasound, MRI when indicated, and image-guided biopsy or localization.

Send DICOM images, not only written reports.

Stage and treatment safety

Stage-appropriate CT, PET-CT or bone evaluation plus blood, heart, fertility, or genetic assessment as clinically indicated.

Not every early cancer requires every body scan.

Admission and treatment

Surgery and pathology

Operation, anesthesia, node mapping, room, routine medicines, specimen work, and margin review.

Define re-excision and drain-care pricing.

Day-care systemic therapy

Named medicines, preparation, nursing, infusion chair, laboratory checks, anti-nausea treatment, and disposables.

Ask whether pharmacy and administration are separate.

Radiotherapy course

Consultation, simulation, planning, physics checks, image guidance, fractions, and weekly review.

Confirm machine and backup schedule.

Recovery and follow-up

Wound, drain, and shoulder care

Dressings, seroma management, range-of-motion support, and early surgical visits.

Know whom to contact after hotel discharge.

Lymphedema and rehabilitation

Baseline assessment, education, physiotherapy, compression, and management when swelling occurs.

Risk differs with node and radiation treatment.

Long-term systemic and surveillance care

Endocrine medicine, biologic infusions, cardiac or bone monitoring, mammography, oncology review, and survivorship support.

Price ongoing care in the home country too.

Complete journey budget

Plan beyond the hospital invoice

Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.

Multi-phase travel

Some patients need separate trips for systemic therapy, surgery, reconstruction, and radiation rather than one continuous stay.

Compare clinical continuity with the cost of repeated flights.

Accessible accommodation and companion

Housing near the treating center, meals, drainage support, and transport during fatigue or limited arm movement.

Daily radiation makes location especially important.

Treatment-delay reserve

Extra nights, repeat blood tests, fever assessment, wound treatment, changed flights, or a delayed radiation start.

Do not exhaust funds on the first operation.

Country access

Rules and practical requirements to verify

Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.

Authorized international provider

Verify that the facility appears on the current Turkish Ministry of Health international-health-tourism list and provides the named oncology services.

Licensed radiation service

If radiotherapy is planned, confirm current department authorization, radiation oncologist, physicist coverage, machine type, quality assurance, and backup for interruptions.

Medicine availability and authorization

A medicine used elsewhere may have different Turkish approval, procurement, or self-pay access. Confirm generic name, indication, brand or biosimilar, dose, and stock in writing.

Pathology and tissue transport

Ask the original and receiving laboratories about consent, release, courier, customs, chain of custody, and return of slides or blocks.

Official visa route

Use the government e-Visa portal or Turkish mission for nationality-specific entry requirements and allow for a treatment schedule that may change.

Hospital selection

Compare capability before package price

Breast multidisciplinary team

Breast surgeon, medical oncologist, radiation oncologist, radiologist, pathologist, plastic surgeon, genetics, and rehabilitation input as relevant.

Ask whether the case is discussed before the sequence is fixed.

Pathology quality

Reliable fixation, receptors, HER2 confirmation, margins, nodes, molecular access, tissue storage, and outside-review process.

Treatment quality depends on pathology quality.

Complete local and systemic capability

Breast and node surgery, reconstruction, chemotherapy, targeted therapy, immunotherapy, radiation, pharmacy, and emergency admission.

Avoid disconnected providers without one accountable plan.

Complication and survivorship support

Infection, thrombosis, neutropenic fever, cardiac monitoring, lymphedema, fertility, psychosocial, and pain services.

Match support to the proposed medicines and operation.

Transparent outcomes and records

Margin, re-operation, wound, reconstruction, treatment-delay, and relevant survival outcomes with definitions and patient group.

Do not accept a universal cure or success percentage.

Treating team

Specialists and support that may matter

Breast surgical oncologist

Plans breast conservation or mastectomy, axillary staging, margins, and the relationship between operation, systemic therapy, and radiation.

Medical oncologist

Uses stage and biology to select chemotherapy, endocrine, HER2-targeted, immune, or other systemic treatment and monitor toxicity.

Radiation oncologist

Defines target areas, technique, fraction schedule, breath or motion management, normal-tissue limits, and follow-up.

Breast pathologist and radiologist

Confirm diagnosis, extent, receptors, response, margins, nodes, and imaging-pathology agreement.

Plastic surgery and rehabilitation team

Supports reconstruction choices, wound recovery, shoulder function, lymphedema prevention, appearance, and return to activity.

Treatment timeline

From report review to return-home follow-up

Remote record review

Share biopsy, receptor results, breast and axillary images, stage studies, symptoms, medicines, illnesses, and fertility or reconstruction priorities.

Arrival confirmation

Resolve pathology or imaging gaps, complete necessary stage and safety testing, and hold multidisciplinary review.

First treatment phase

Proceed with surgery or neoadjuvant systemic therapy according to stage, biology, operability, and patient goals.

Definitive local care

Surgery, margins, nodes, reconstruction, and postoperative pathology define the next steps.

Adjuvant or advanced therapy

Radiation and systemic treatment are delivered according to pathology, response, recurrence risk, and tolerance.

Return-home continuity

The home team receives pathology, stage, operation, drugs and doses, radiation plan, toxicities, rehabilitation, surveillance, and urgent warning signs.

Risks and edge cases

Events that can change the plan, stay, or cost

Positive or close margin

A second breast operation or conversion to mastectomy may be discussed after final pathology.

Ask whether re-excision is included or separately priced.

Wound, seroma, or reconstruction problem

Aspiration, antibiotics, implant removal, flap treatment, readmission, or delayed systemic therapy may be necessary.

Confirm plastic-surgery and infection coverage.

Neutropenic fever or severe toxicity

Urgent blood tests, antibiotics, growth factor, transfusion, or inpatient care can interrupt the planned cycle schedule.

Know the 24-hour emergency route before infusion.

Cardiac toxicity

Selected chemotherapy and HER2-directed medicines can require baseline and repeat cardiac assessment or treatment changes.

Arrange monitoring after return home.

Pregnancy or fertility concern

Imaging, surgery, medicines, radiation, contraception, and preservation decisions require specialized timing.

Raise this before the first dose or operation.

Destination comparison

Compare India, Turkey, and Thailand for this procedure

The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.

Procedure planning comparison across India, Turkey, and Thailand
Decision factor	India	Turkey	Thailand	How to use this
Multimodal access	Many large oncology programs across metros and selected value cities.	Strong integrated private and academic care in Istanbul, Ankara, and selected regional centers.	Advanced private oncology is concentrated mainly in Bangkok and a few hubs.	Compare the whole sequence and responsible team, not country reputation.
Drug and quote currency	INR and USD estimates with brand and biosimilar variation.	TRY, EUR, or USD may be used for imported biologics and implants.	THB private-hospital pricing can vary markedly by originator medicine.	Compare generic name, brand, dose, number of administrations, and conversion date.
Radiation and reconstruction logistics	Wide availability but city and center capability varies.	Major centers can integrate breast surgery, reconstruction, and modern radiation.	High-end integrated programs exist with potentially higher accommodation costs.	Confirm timing, machine, fractions, and revision care before travel.
Long-term continuity	Remote follow-up varies by institution and home-country access.	Geographic proximity can help Europe, Central Asia, the Middle East, and North Africa.	Longer travel may complicate repeated biologic treatment for western patients.	Choose a plan that can continue medicines, imaging, and emergency care at home.

Decision guidance

When Turkey may fit and when to keep comparing

Turkey may fit when

A current authorized center confirms pathology and stage, gives one multidisciplinary sequence, names drugs and radiation scope, and provides practical home handover.

Keep comparing when

The quotation is only for surgery despite likely radiation or systemic care, omits receptor confirmation, uses unnamed cancer medicines, or guarantees cure.

Seek another review when

Surgery-first and medicine-first recommendations conflict, mastectomy is proposed without discussing conservation where relevant, or reconstruction timing ignores radiation.

Use urgent local care when

There is fever during treatment, breathing difficulty, chest pain, confusion, uncontrolled bleeding, severe dehydration, or rapidly worsening symptoms.

Reports for review

Prepare a case file before requesting estimates

Build one chronological file that lets the team verify diagnosis, biology, extent, treatment already received, and personal priorities. Include original imaging and pathology material where legally and practically available; a translated summary is helpful but should not replace source reports and images.

Upload medical reports

Pathology and biology

Core-biopsy and operation reports

Provide the complete core-biopsy and operation reports with specimen dates and sites.

ER, PR, HER2, grade, and proliferation

Include methods, scores, confirmatory testing, and any discordant results.

Slides or blocks availability

State what tissue can be released, reviewed, returned, or sent for genomic analysis.

Genetic or genomic results

Include germline and tumor assays already performed with the laboratory and date.

Imaging and stage

Mammography, ultrasound, and MRI

Send DICOM studies plus reports and mark the biopsied lesion.

Axillary assessment

Include node ultrasound, needle sampling, or sentinel-node information.

CT, PET-CT, or bone studies

Provide only studies performed with dates and source files.

Clinical stage and symptoms

Summarize breast, skin, node, pain, breathing, neurologic, or other symptoms.

Treatment and safety

All prior cancer treatment

List operations, radiation fields and doses, medicines, dates, responses, and toxicities.

Heart, blood, kidney, and liver tests

Provide recent safety results relevant to systemic treatment and surgery.

Medicines, allergies, pregnancy, and fertility

Include contraception, menopause, supplements, anticoagulants, and preservation discussions.

Travel and home-care contacts

Add passport nationality, companion needs, home oncologist, pharmacy access, and preferred treatment window.

Common questions

Questions about cost, travel, and follow-up

Is breast cancer surgery the complete treatment cost?

Often not. Radiation, chemotherapy, endocrine therapy, targeted treatment, immunotherapy, reconstruction, pathology, and surveillance may be separate phases.

Does a lumpectomy cost less than mastectomy?

The operation may cost less, but a fair comparison includes likely radiation, margin re-excision risk, reconstruction, recovery, and the individual oncologic plan.

Are chemotherapy medicines included?

Only when the estimate names each medicine, brand or biosimilar, dose, interval, planned cycles, administration, laboratory checks, and supportive drugs.

Can I choose immediate reconstruction?

Possibly, but cancer extent, smoking, diabetes, body anatomy, systemic treatment, radiation likelihood, donor tissue, and personal priorities affect timing and method.

Why might chemotherapy come before surgery?

For selected biology or stage, pre-operative therapy can treat systemic risk, shrink disease, and show response, while the exact rationale should be explained by the team.

How long does treatment in Turkey take?

Surgery may require weeks around recovery, while chemotherapy, targeted therapy, endocrine treatment, and radiation can extend over months or years. Some phases can transfer home.

Can I complete radiation at home?

Potentially, if the home center accepts the pathology, operation, imaging, and planning information and the oncology teams coordinate timing and indications.

What if Turkey pathology differs from my original report?

Pause irreversible treatment while the teams reconcile specimen identity, methods, slides, receptor results, and the clinical implications of the discrepancy.

How should HER2 treatment be priced?

Ask for generic name, originator or biosimilar, loading and maintenance doses, administration interval, planned duration, heart monitoring, and toxicity care.

When is fever an emergency?

Fever during chemotherapy or other immune-suppressing treatment can signal serious infection. Follow the oncology team’s emergency threshold and seek immediate assessment rather than waiting for a flight.

Review and sources

How this guide was prepared

This guide separates surgery-only pricing from a complete stage- and biology-led treatment pathway. Public Turkey market signals were normalized into broad planning scenarios near the 17 July 2026 official exchange rate, then tested against procedure, reconstruction, radiation-course, medicine, toxicity, and follow-up components. Clinical structure was checked against current NCI treatment material and Turkish provider and radiation-service rules. No starting price, drug list, or hospital claim was treated as an individual prescription or guaranteed tariff.

This guide is educational and cannot confirm a cancer diagnosis, stage, surgery, medicine, radiation plan, prognosis, pregnancy safety, or travel fitness. Treatment must follow pathology and multidisciplinary review with a time-limited written hospital quotation. Fever during systemic therapy, breathing difficulty, chest pain, confusion, uncontrolled bleeding, severe dehydration, or rapidly worsening symptoms requires urgent local assessment.

Related planning